Stryker to invest $400m in CMR Surgical
Medical technology company Stryker is set to invest approximately $400 million in UK-based robot surgery firm CMR Surgical. The deal also includes an option for outright acquisition.
US-listed medical technology firm Stryker is poised to invest approximately $400 million in UK-based CMR Surgical, a company specializing in robotic surgical systems. The agreement also grants Stryker an option to acquire CMR Surgical outright.
Under the terms of the deal, Stryker will also serve as the exclusive US sales agent for CMR Surgical's robot-assisted surgery system. This partnership aims to expand the reach of CMR Surgical's technology within the significant North American healthcare market.
CMR Surgical has previously secured substantial funding from investors such as Softbank and Lightrock, focusing on advancing the adoption of robotic surgery globally. This investment from Stryker provides significant capital to accelerate its growth and development.
The collaboration is expected to bolster CMR Surgical's market presence and technological advancements. Stryker's established position in the medical technology sector is anticipated to support CMR Surgical's expansion efforts, particularly in the United States.